code,description
5135.,Radiological tumour control
514..,Purpose of radiotherapy
5141.,Radiotherapy for immunosuppression
5142.,Radiotherapy for haemopoietic irradiation
5143.,Radiotherapy for lymphatic irradiation
5144.,Preoperative course of radiotherapy
5145.,Radiotherapy - intraoperative control
5146.,Postoperative course of radiotherapy
5147.,Radiotherapy for analgesia
5148.,Radiotherapy for inflammation
5149.,Palliative course of radiotherapy
514Z.,Radiotherapy purpose - NOS
515..,Progress of radiotherapy
5151.,Radiotherapy started
5152.,Radiotherapy changed
5153.,Radiotherapy stopped
5154.,Radiotherapy completed
515Z.,Radiotherapy progress NOS
56B5.,Image: field control:radiother
591..,X-ray beam therapy
5911.,Grenz ray therapy up to 10 kV
5912.,Superficial X-ray therapy 10-60 kV
5913.,Half-deep therapy 60-150 kV
5914.,Deep X-ray therapy 150-400 kV
5915.,Ultrahard X-rays 400-2000 kV
5916.,Short distance X-ray therapy
5917.,Intracavitary X-ray therapy
5918.,Combined X-ray therapy
591Z.,X-ray beam therapy NOS
592..,High-energy beam therapy
5921.,Linear accelerator photon therapy
5922.,Betatron photon therapy
5923.,Van der Graaff photon therapy
5924.,Combined photon therapy
592Z.,High-energy beam therapy NOS
593..,Fast-electron therapy
5931.,Linear accelerator electrons
5932.,Betatron electron therapy
5933.,Positron therapy
5934.,Combined fast-electron therapy
593Z.,Fast-electron therapy NOS
594..,Heavy particle therapy
5941.,Proton therapy
5942.,Deuteron therapy
5943.,Pi-meson therapy
5944.,Neutron capture therapy
5945.,Fast neutron therapy
5946.,Combined heavy particle therapy
594Z.,Heavy particle therapy NOS
595..,Gamma ray and intermediate distance curietherapy
5951.,Gamma-ray telecurie therapy
5952.,Intermediate distance curietherapy
5953.,Combined teletherapy and intermediate distance curietherapy
595Z.,Distant gamma therapy NOS
596..,Short distance and contact radiotherapy
5961.,Radium contact therapy
5962.,Beta source contact therapy
5963.,Mould technique gamma/beta
596Z.,Short distance/contact radiotherapy NOS
597..,Combined radiotherapy
5971.,External beam with internal radiotherapy
5972.,External beam - surgery with preoperative radiotherapy
5973.,External beam - surgery with postoperative radiotherapy
5974.,External beam - surgery with chemotherapy
5975.,External beam with chemotherapy
597Z.,Combined radiotherapy NOS
59Z..,External radiotherapy NOS
5A...,(Radiotherapy - internal) or (other nuclear therapy)
5A1..,Internal metabolic radiotherapy
5A11.,Thyroid gland ablation - irradiation
5A12.,Thyroid tumour/metastasis irradiation
5A13.,Bone marrow suppression - irradiation
5A14.,Polycythaemia irradiation
5A15.,Bone tumour/metastasis irradiation
5A16.,Radioactive drug therapy
5A17.,Combined internal radiotherapy
5A1Z.,Internal metabolic radiotherapy NOS
5A2..,Internal radiotherapy - unsealed source
5A21.,Radiotherapy: infuse skull/brain
5A22.,Radiotherapy: infuse head/neck
5A23.,Radiotherapy: infuse pleural cavity
5A24.,Radiotherapy: infuse peritoneal cavity
5A25.,Radiotherapy: endolymphatic infusion
5A26.,Radiotherapy: infuse urinary bladder
5A27.,Radiotherapy: infuse organ cavity
5A28.,Radiotherapy: infiltrate tissue
5A2Z.,Internal unsealed radiotherapy NOS
5A3..,Internal radiotherapy - permanent seeds
5A31.,Radiotherapy: seeds into hypophysis
5A32.,Radiotherapy: seeds into brain
5A33.,Radiotherapy: seeds into cavity
5A3Z.,Radiotherapy: permanent seeds NOS
5A4..,Radiotherapy implant: [needles] or [therapy]
5A41.,Radiotherapy: temporary brain implant
5A42.,Radiotherapy: temporary head/neck implant
5A43.,Radiotherapy: temporary tongue implant
5A44.,Radiotherapy: temporary thorax implant
5A45.,Radiotherapy: temporary abdominal implant
5A46.,Radiotherapy: temporary pelvic implant
5A47.,Radiotherapy: temporary limb implant
5A48.,Radiotherapy: temporary lymphatic implant
5A4Z.,Radiotherapy: temporary implant NOS
5A5..,Preload cavity radiotherapy - sealed
5A51.,Preload radiotherapy - orbit
5A52.,Preload radiotherapy - paranasal sinus
5A53.,Preload radiotherapy - nose
5A54.,Preload radiotherapy - mouth
5A55.,Preload radiotherapy - ear
5A56.,Preload radiotherapy - upper gastrointestinal tract
5A57.,Preload radiotherapy - respiratory organs
5A58.,Preload radiotherapy - female genital
5A59.,Preload radiotherapy - urinary system
5A5A.,Preload radiotherapy - rectum
5A5B.,Preload radioth.- OP cavity
5A5Z.,Preload cavity radiotherapy NOS
5A6..,Afterloading cavity radiotherapy
5A61.,Afterload radiotherapy - head
5A62.,Afterload radiotherapy - upper gastrointestinal tract
5A63.,Afterload radiotherapy - respiratory system
5A64.,Afterload radiotherapy - female genital
5A65.,Afterload radiotherapy - urinary
5A66.,Afterload radiotherapy - rectum
5A67.,Afterload radioth.- OP cavity
5A6Z.,Afterload cavity radiotherapy NOS
5A7..,Radiomimetic chemotherapy
5A71.,Radiochemotherapy: local infiltration
5A72.,Radiochemotherapy: to stop spread
5A73.,Radiochemotherapy: oral route
5A74.,Radiochemotherapy: IV route
5A75.,Radiochemotherapy: for immunosuppression
5A76.,Radiochemotherapy: local artery
5A77.,Radiochemotherapy: into cavity
5A7Z.,Radiochemotherapy NOS
5A8..,Other radiotherapy misc.
5A81.,Give radiosensitising drug
5A82.,Radiosensitising measure
5A83.,Radioprotective drug
5A8Z.,Other radiotherapy NOS
5AZ..,Other nuclear therapy NOS
65NZ.,Prophylactic chemotherapy NOS
70462,Intrathecal injection of chemotherapeutic agent
70522,Radiotherapy to lesion of peripheral nerve
71011,Implantation of radioactive substance into pituitary gland
72201,Radiotherapy to lacrimal gland
72444,Radiotherapy of corneal lesion
72722,Radiotherapy to lesion of retina
7D034,Implantation of radioactive substance into vulva
7D154,Implantation of radioactive substance into vagina
7E0C0,Introduction of radioactive substance into uterine cavity
7H2C0,Intraperitoneal administration of radioactive substance
7M0P.,Introduction removable radioactive material into organ NOC
7M0P0,Introduction of radioactive caesium into organ NOC
7M0P1,Introduction of iridium wire into organ NOC
7M0P2,Introduction of radium into organ NOC
7M0Py,Introduction removable radioactive material to organ NOC OS
7M0Pz,Introduction removable radioactive material to organ NOC NOS
7M371,Radiotherapy NEC
863..,Phototherapy &/or radiation therapy
863Z.,Radiation/phototherapy NOS
8BA5.,Oral chemotherapy (& cytotoxic)
8BAD0,Cancer chemotherapy
8BAD1,TB chemotherapy
8H2G.,Admit radiotherapy emergency
8H3L.,Non-urgent radiotherapy admission
8H67.,Referred for radiotherapy
8HB5.,Combined therapy follow-up
8HB7.,Chemotherapy follow-up
8J...,Radiotherapy treatment groups
8J0..,Brachytherapy
8J1..,Teletherapy
9N1yC,Seen in radiotherapy clinic
D2013,Aplastic anaemia due to radiation
SL07.,Antineoplastic antibiotic poisoning
SL070,Cactinomycin poisoning
SL073,Daunorubicin poisoning
SL07z,Antineoplastic antibiotic poisoning NOS
TA32.,Overdose of radiation in therapy
TB121,"Radiotherapy procedure with complication, without blame"
TJ07.,Adverse reaction to antineoplastic antibiotics
TJ070,Adverse reaction to actinomycin D
TJ071,Adverse reaction to bleomycin
TJ072,Adverse reaction to doxorubicin hydrochloride
TJ073,Adverse reaction to mitomycin
TJ074,Adverse reaction to plicamycin
TJ07z,Adverse reaction to antineoplastic antibiotics NOS
TJ310,Adverse reaction to busulfan
TJ311,Adverse reaction to carmustine
TJ312,Adverse reaction to chlorambucil
TJ313,Adverse reaction to cyclophosphamide
TJ314,Adverse reaction to estramustine phosphate
TJ315,Adverse reaction to lomustine
TJ316,Adverse reaction to melphalan
TJ317,Adverse reaction to chlormethine hydrochloride
TJ318,Adverse reaction to thiotepa
TJ319,Adverse reaction to treosulphan
TJ31A,Adverse reaction to cytarabine
TJ31B,Adverse reaction to fluorouracil
TJ31C,Adverse reaction to mercaptopurine
TJ31D,Adverse reaction to methotrexate
TJ31E,Adverse reaction to tioguanine
TJ31F,Adverse reaction to etoposide
TJ31G,Adverse reaction to vinblastine sulphate
TJ31H,Adverse reaction to vincristine sulphate
TJ31J,Adverse reaction to carboplatin
TJ31K,Adverse reaction to cisplatin
TJ31L,Adverse reaction to hydroxycarbamide
TJ31M,Adverse reaction to mitoxantrone
TJ31N,Adverse reaction to procarbazine
TJ31P,Adverse reaction to razoxane
TJ31z,Adverse reaction to antineoplastic/immunosuppress drugs NOS
U6031,[X]Antineoplast antimetabs caus adverse eff in therap use
U6032,[X]Antineoplast natural prod caus adverse eff in therap use
U6033,[X]Other antineoplast drugs caus adverse eff in therap use
U6132,[X]Overdose of radiation given during therapy
Ub0w0,Radiotherapy procedures
Ub0w2,Superficial X-ray therapy
Ub0w4,Grenz ray therapy
Ub0w5,Orthovoltage X-ray therapy
Ub0w6,Megavoltage X-ray therapy
Ub0w7,Linear accelerator X-ray therapy
Ub0w8,Betatron X-ray therapy
Ub0w9,Microtron X-ray therapy
Ub0wA,Van der Graaff X-ray therapy
Ub0wB,Gamma ray teletherapy
Ub0wC,Caesium 137 teletherapy
Ub0wD,Cobalt 60 teletherapy
Ub0wE,Teletherapy with dual headed cobalt unit
Ub0wF,Stereotactic cobalt teletherapy
Ub0wG,Radium 226 teletherapy
Ub0wH,Teletherapy with radium collar
Ub0wI,Electron teletherapy
Ub0wJ,Linear accelerator electron teletherapy
Ub0wK,Betatron electron teletherapy
Ub0wL,Microtron electron teletherapy
Ub0wM,Strontium 90 electron teletherapy
Ub0wN,Neutron teletherapy
Ub0wO,Cyclotron neutron teletherapy
Ub0wP,Deuterium on tritium neutron teletherapy
Ub0wQ,Hiletron neutron teletherapy
Ub0wR,Proton teletherapy
Ub0wT,Caesium 137 brachytherapy
Ub0wU,Caesium 137 brachytherapy manual loading
Ub0wV,Caesium 137 brachytherapy manual loading Heyman's capsules
Ub0wW,Curietron brachytherapy
Ub0wX,Cobalt 60 brachytherapy
Ub0wY,Cobalt 60 brachytherapy manual loading
Ub0wZ,Cathetron brachytherapy
Ub0wa,Iridium 192 brachytherapy
Ub0wb,Gammamed brachytherapy
Ub0wc,Microselectron brachytherapy
Ub0wd,Selectron brachytherapy
Ub0we,Californium 252 brachytherapy
Ub0wf,Gold 198 brachytherapy
Ub0wg,Iodine 125 brachytherapy
Ub0wh,Phosphorus 32 brachytherapy
Ub0wi,Radium 226 brachytherapy
Ub0wj,Radon 222 brachytherapy
Ub0wk,Ruthenium 106 brachytherapy
Ub0wl,Strontium 90 brachytherapy
Ub0wm,Tantalum 182 brachytherapy
Ub0wn,Yttrium 90 brachytherapy
Ub0wo,Radionuclide therapy
Ub0wp,Yttrium 90 therapy
Ub0wq,Iodine 131 therapy
Ub0wr,Phosphorus 32 therapy
Ub0ws,Iodine 131 meta-iodobenzylguanidine therapy
Ub0wt,Strontium 89 therapy
Ub0wu,Gold 198 therapy
Ub0wv,Radiotherapy planning
Ub0ww,Radiotherapy planning using a free set up
Ub0wx,Radiotherapy planning using a simulator
Ub0wy,Radiotherapy planning using simulator fluoroscopy
Ub0wz,Radiotherapy planning using a simulator X-ray film
Ub0x0,Radiotherapy planning using diagnostic radiology
Ub0x4,Radiotherapy planning using computerised tomography
Ub0x5,Radiotherapy planning using magnetic resonance imaging
Ub0x6,Radiotherapy planning using mould room preparation
Ub0x7,Making of beam direction shell for radiotherapy
Ub0x8,Making of bite block for radiotherapy
Ub0x9,Making of bolus block for radiotherapy
Ub0xA,Making of compensator for radiotherapy
Ub0xB,Making of cut-out for radiotherapy
Ub0xC,Making of docking unit for radiotherapy
Ub0xD,Making of template for radiotherapy
Ub0xE,Making of shielding block for radiotherapy
Ub0xF,Making of surface mould for brachytherapy
Ub0xG,Radiotherapy calculation
Ub0xH,Calculation of teletherapy
Ub0xI,Calculation of teletherapy parameters
Ub0xJ,Outlining for radiotherapy dose calculation
Ub0xK,Calculation of radiotherapy isodose distribution
Ub0xL,Calculation of radiotherapy dose corrections
Ub0xM,Calculation of radiotherapy dose-volume histogram
Ub0xN,Calculation of brachytherapy
Ub0xO,Calculation of radionuclide therapy
Ub1Pe,Pulsed electromagnetic energy therapy
X00Te,Radiotherapy to orbital lesion
X00U8,Radiotherapy to lesion of medial canthus
X00UQ,Radiotherapy to lesion of lateral canthus
X00X9,Radiotherapy to ciliary body
X00Xi,Radiotherapy to retina
X00Y8,Radiotherapy to lesion of choroid
X20by,Bile duct endoluminal radiotherapy
X71bL,Chemotherapy
XC0gO,Radioactive iodine therapy
XE0Jb,Intravenous chemotherapy
XE0Jc,Intramuscular chemotherapy
XE0Je,Subcutaneous chemotherapy
XE0hv,Oral chemotherapy
XE14D,Neutropenia due to irradiation
XE1Rx,Radioactive drug therapy (& I131)
XE1Sk,Prophylactic chemotherapy
XE2r3,Temporary implant radiotherapy
XE2rh,Other nuclear therapy
XS90X,Treatment planning for brachytherapy
Xa3yl,Cytotoxic given orally
Xa3yn,Cytotoxic drug therapy NOS
Xa4sx,Accidental daunorubicin poisoning
Xa4sy,Intentional daunorubicin poisoning
Xa4sz,Daunorubicin poisoning of undetermined intent
Xa7mv,Radiotherapy to lesion of canthus
Xa8SI,Radiotherapy
Xa97L,Radiotherapy - internal
XaC0F,Continuous infusion of chemotherapy
XaC0G,Intramuscular injection of Methotrexate
XaC0H,Intravenous injection of Methotrexate
XaC0n,Diagnostic intravenous injection of Camsilon
XaDn1,X-ray teletherapy
XaDn2,Radiolabelled antibody therapy
XaDok,Caesium 137 brachytherapy remote afterloading
XaDol,Cobalt 60 brachytherapy remote afterloading
XaDor,Iridium 192 brachytherapy remote afterloading
XaDot,Heavy ion teletherapy
XaDp8,Radiotherapy mould room procedure
XaDzO,Intramuscular injection of betamethasone
XaECT,Electromagnetic energy therapy
XaFBN,Palliative course of deep X-ray therapy
XaFBO,Preoperative course of deep X-ray therapy
XaFBP,Postoperative course of deep X-ray therapy
XaFz7,Treatment planning for teletherapy
XaI8k,Ambulatory chemotherapy
XaIR9,Awaiting radiotherapy
XaIky,Pre-operative chemotherapy
XaIkz,Post-operartive chemotherapy
XaIl6,High dose brachytherapy
XaImG,Iodine seed radiotherapy
XaIme,Combined pre-operative chemotherapy and radiotherapy
XaImf,Combined post-operative chemotherapy and radiotherapy
XaIpD,Selectron therapy
XaIpE,Iridium wire therapy
XaIpe,Stereotactic radiotherapy
XaJr8,Intramuscular injection of methylprednisolone
XaKwV,Chemotherapy started
XaL5K,Plaque radiotherapy to lesion of retina
XaLbh,Stereotactic radiosurgery on tissue of brain
XaLdq,Selective internal radiotherapy microspheres lesion of liver
XaLdr,Percutaneous radiofrequency ablation of lesion of liver
XaLuJ,External beam radiotherapy to lesion of retina
XaLyT,Radioactive seed implantation NOC
XaLyX,Intro radioactive substance org interstit brachytherapy NOC
XaLzs,Other specified radiotherapy procedures
XaLzt,Radiotherapy procedures NOS
XaLzu,Delivery fraction complex radiotherapy megavoltage machine
XaLzv,Delivery fraction simple radiotherapy megavoltage machine
XaLzw,Delivery fraction radiotherapy superficial orthovoltage mach
XaM2B,Radiotherapy delivery
XaM2C,Delivery of a fraction of total body irradiation (TBI)
XaM2E,Delivery of a fraction of intracavitary radiotherapy
XaM2F,Delivery of a fraction of interstitial radiotherapy
XaM2G,Other specified radiotherapy delivery
XaM2H,Radiotherapy delivery NOS
XaM2M,Rad prep ([AND/OR] prep for ext beam rad AND/OR brachythera)
XaM2N,Preparation for total body irradiation
XaM2O,Prep for intracavitary radiotherapy ([AND/OR] brachytherapy)
XaM2P,Prep for interstitial radiotherapy ([AND/OR] brachytherapy)
XaM2Q,Other spec rad prep ([AND/OR] other spec prep ext beam rad)
XaM2R,Radiothp prep NOS ([AND/OR] prep for ext beam radiothp NOS)
XaM2S,Radio vol definition ([AND/OR] prep ex beam radio OR brachy)
XaM2T,Prep ([AND/OR] vol def radiotherapy imag and IMRT dosimetry)
XaM2U,"Prep ([AND/OR] vol def for radioth with imag, dos tech supp)"
XaM2V,Prep ([AND/OR] vol def mult phases complx radioth with dosim
XaM2W,Vol def ([AND/OR] prep for simpl radioth with imag dosimtry)
XaM2X,Vol defin ([AND/OR] prep) for simp radio imag and simpl calc
XaM2Y,"Prep ([AND/OR] vol de sup deep X-ray, ele megav rad si calc)"
XaM2Z,Oth spec rad vol definition ([AND/OR] prep for ext beam rad)
XaM2a,Rad vol defin ([AND/OR] prep for externl beam radiother) NOS
XaM49,Chemotherapy delivery
XaM4A,Delivery of chemotherapy for neoplasm
XaM4B,Del comp chemo neo inc prolong infusion treat first attend
XaM4C,Deliv complex parenteral chemotherapy neopl first attendance
XaM4D,Deliver simple parenteral chemother neoplas first attendance
XaM4E,Delivery subsequent element cycle chemotherapy for neoplasm
XaM4F,Other specified delivery of chemotherapy for neoplasm
XaM4G,Delivery of chemotherapy for neoplasm NOS
XaM4H,Delivery of oral chemotherapy for neoplasm
XaM4I,Delivery of exclusively oral chemotherapy for neoplasm
XaM4J,Other specified delivery of oral chemotherapy for neoplasm
XaM4L,Delivery of oral chemotherapy for neoplasm NOS
XaM4w,Percutaneous radiofrequency ablation of lesion of kidney
XaMAv,Endoscopic radiofrequency ablation of lesion of prostate
XaMB1,Transurethral radiofrequency needle ablation of prostate
XaMOH,Seed implantation into prostate
XaMlE,Percutaneous radiofrequency ablation of lesion of lung
XaMtr,Delivery of a fraction of external beam radiotherapy NEC
XaMuE,Oral delivery of radiotherapy for thyroid ablation
XaMv7,Radioactive seed implantation into prostate
XaNS5,Radiotherapy to perineum
XaNS6,Radiotherapy to abdomen
XaNS7,Radiotherapy to neck
XaNS8,Radiotherapy to chest wall
XaNSA,Radiotherapy to axilla
XaNSB,Radiotherapy to breast
XaNSC,Radiotherapy to head
XaNSD,Radiotherapy to pelvis
XaNSR,Radiotherapy by body site
XaPt9,Percutaneous radiofrequency ablation of lesion of bone
XaPuI,Preparation for external beam radiotherapy
XaPuJ,Preparation for intensity modulated radiation therapy
XaPuL,Preparation for hemi body irradiation
XaPuM,Preparation for simp radiotherapy with imaging and dosimetry
XaPuN,Prep for simple radioth with imaging and simple calculation
XaPuO,Prepar for superficial radiotherapy with simple calculation
XaPuP,Preparation for complex conformal radiotherapy
XaPuQ,Other specified preparation for external beam radiotherapy
XaPuR,Preparation for external beam radiotherapy NOS
XaPuS,Preparation for brachytherapy
XaPuT,Preparation for intraluminal brachytherapy
XaPuU,Preparation for intracavitary brachytherapy
XaPuV,Preparation for interstitial brachytherapy
XaPuW,Other specified preparation for brachytherapy
XaPuX,Preparation for brachytherapy NOS
XaPve,Megavoltage treatment for complex radiotherapy
XaPvf,Megavoltage treatment for simple radiotherapy
XaPvg,Superficial or orthovoltage treatment for radiotherapy
XaPvh,Megavoltage treatment for adaptive radiotherapy
XaPvi,Technical support for preparation for radiotherapy
XaPvj,Other specified support for preparation for radiotherapy
XaPvk,Support for preparation for radiotherapy NOS
XaPvl,Support for preparation for radiotherapy
XaPvm,Intro radioactive substance into organ for brachytherapy NOC
XaPvn,Intro non-remov radioact subst into organ for brachyther NOC
XaPw8,Delivery of a fraction of intraluminal brachytherapy
XaVwB,Cancer chemotherapy management plan
XaZD3,Neoadjuvant chemotherapy
XaZWZ,Electrochemotherapy
Xaaqq,Hypofractionated SRT using megavoltage radiation
Xaaw6,High cost chemotherapy drugs
Xaawm,Pulsed dose rate brachytherapy
Y035e,Radiotherapy to head
Y035f,Radiotherapy to neck
Y036a,Radiotherapy to breast
Y036b,Radiotherapy to axilla
Y036c,Radiotherapy to subclavia
Y036d,Radiotherapy to chest wall
Y036e,Radiotherapy to pelvis
Y036f,Radiotherapy to abdomen
Y037a,Radiotherapy to perineum
Y037b,Radiotherapy to bone
ZV073,[V]Other prophylactic chemotherapy
ZV580,[V]Radiotherapy session
ZV581,[V]Maintenance chemotherapy
ZV588,[V]Chemotherapy session for neoplasm
ZV661,[V]Convalescence after radiotherapy
ZV672,[V]Chemotherapy follow-up
ZV678,[V]Follow-up examin after chemotherapy for malign neoplasm
ZV679,[V]Follow-up exam aft combined treatment for malig neoplasm
ZV6B1,[V]Follow-up exam after chemotherapy for other conditions
ZVu0C,[X]Follow-up examinat after radiother for other conditions
ZVu0D,[X]Follow-up examinat after chemother for other conditions
ZVu3L,[X]Other chemotherapy
